Results 11 - 20 of 4004 : Previous 1 2 3 4 5 6 7 8 9 Next
Curing Diseases Makes For a Bad Business Model
Vertex got to a lot of patients quickly, but now what?
This Just In: Upgrades and Downgrades
Bank of America relents on Dendreon.
Has Elan Become the Perfect Stock?
Finding companies that have all the right stuff can produce winners.
The Dow stocks that fell the most today.
The Disadvantage of a Successful Pipeline
Biogen ramps up R&D spending.
Pfizer loses Lipitor exclusivity and still beats analysts.
Breaking down the market.
Sometimes it takes more than one indication to really shine.